person · Reporting owner

Cunningham Everett

Disclosed activity across 5 companies

Tapewire entity: 35100
SEC CIK: 0001564777

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ARVINAS, INC.ARVN · Entity 5355	Director	June 24, 2026	June 26, 2026
EXACT SCIENCES CORPEXAS · Entity 56619	Chief Commercial Officer	April 30, 2024	May 02, 2024
ILLUMINA, INC.ILMN · Entity 3137	SVP, Chief Commercial Officer	July 05, 2025	July 08, 2025
QUEST DIAGNOSTICS INCDGX · Entity 2118	SVP, Commercial	March 01, 2018	March 25, 2019
Quanterix CorpQTRX · Entity 6649	Director · President and CEO	January 19, 2026	January 21, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARVINAS, INC.

Report date June 24, 2026 · Filed June 26, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	41,572	Reported balance After 2026-06-24 transaction · row 1 1 source row Row 1 · 2026-06-24 · Grant · Acquired 15,527 · Balance 41,572 F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 24, 2026 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2036-06-23	Direct	22,714	Reported balance After 2026-06-24 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-24 · Grant · Acquired 22,714 · Balance 22,714 F2: This option award was granted on June 24, 2026. The shares underlying the award shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 24, 2026 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date.

F2: This option award was granted on June 24, 2026. The shares underlying the award shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date.

EXACT SCIENCES CORP

Report date April 30, 2024 · Filed May 02, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	46,470	Reported balance After 2024-04-30 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2024-04-30 · Grant · Acquired 291 · Balance 46,470 F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024. F2: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Common StockSEC Table I · non-derivative	Direct	47,178	Reported balance After 2024-04-30 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2024-04-30 · Grant · Acquired 708 · Balance 47,178 F3: Represents shares of common stock purchased through Employee Stock Purchase Plan. F2: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Common StockSEC Table I · non-derivative	Direct	47,042	Reported balance After 2024-05-01 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2024-05-01 · Sale · Disposed 136 · Balance 47,042 F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
Common StockSEC Table I · non-derivative	IndirectHeld in 401(k) Plan	571	Reported balance Holding disclosure · report date 2024-04-30 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 571

Filing footnotes · ownership attribution and instrument terms

F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.

F2: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

F3: Represents shares of common stock purchased through Employee Stock Purchase Plan.

F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.

ILLUMINA, INC.

Report date July 05, 2025 · Filed July 08, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	41,942	Reported balance After 2025-07-05 transaction · row 1 1 source row Row 1 · 2025-07-05 · Tax withholding · Disposed 4,248 · Balance 41,942
Common StockSEC Table I · non-derivative	IndirectBeneficiary IRA	70	Reported balance Holding disclosure · report date 2025-07-05 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 70
Common StockSEC Table I · non-derivative	IndirectIRA	757	Reported balance Holding disclosure · report date 2025-07-05 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 757
Common StockSEC Table I · non-derivative	IndirectRevocable Trust	3,151	Reported balance Holding disclosure · report date 2025-07-05 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 3,151
Common StockSEC Table I · non-derivative	IndirectSpouse IRA	672	Reported balance Holding disclosure · report date 2025-07-05 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 672

QUEST DIAGNOSTICS INC

Report date March 01, 2018 · Filed March 25, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	37,760	Reported balance After 2018-03-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-03-01 · Gift · Disposed 491 · Balance 37,760 F1: This late reporting of a charitable gift is due to an inadvertent administrative error. F2: This total reflects the current amount of securities beneficially owned by the reporting person as of the filing date of this Form 4. For Form 4s filed by this reporting person since March 1, 2018, this column erroneously included the 491 shares reported herein as a charitable gift. In the Form 4 filed on March 4, 2019, this column also erroneously included 60 shares due to over-reporting of exempt purchases made by the reporting person under the Company's stock purchase plan.
Common StockSEC Table I · non-derivative	Indirect401(k)	721	Reported balance Holding disclosure · report date 2018-03-01 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 721 F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Filing footnotes · ownership attribution and instrument terms

F1: This late reporting of a charitable gift is due to an inadvertent administrative error.

F2: This total reflects the current amount of securities beneficially owned by the reporting person as of the filing date of this Form 4. For Form 4s filed by this reporting person since March 1, 2018, this column erroneously included the 491 shares reported herein as a charitable gift. In the Form 4 filed on March 4, 2019, this column also erroneously included 60 shares due to over-reporting of exempt purchases made by the reporting person under the Company's stock purchase plan.

F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Quanterix Corp

Report date January 19, 2026 · Filed January 21, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2030-01-20	Direct	813,750	Reported balance After 2026-01-19 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-01-19 · Grant · Acquired 813,750 · Balance 813,750 F1: Each performance-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The performance-based RSUs vest upon the volume-weighted average price of the Issuer's common stock meeting certain thresholds within a four-year period, except as provided for under Section 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026.
Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2030-01-20	Direct	1,883,750	Reported balance After 2026-01-19 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-01-19 · Grant · Acquired 1,070,000 · Balance 1,883,750 F2: Each time-based RSU represents a contingent right to receive one share of the Issuer's common stock. The time-based RSUs vest as to one-fourth of the total number of shares on each of January 19, 2027, January 19, 2028, January 19, 2029 and January 19, 2030, except as provided for under Section 8(d) or 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Each performance-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The performance-based RSUs vest upon the volume-weighted average price of the Issuer's common stock meeting certain thresholds within a four-year period, except as provided for under Section 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026.

F2: Each time-based RSU represents a contingent right to receive one share of the Issuer's common stock. The time-based RSUs vest as to one-fourth of the total number of shares on each of January 19, 2027, January 19, 2028, January 19, 2029 and January 19, 2030, except as provided for under Section 8(d) or 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 24, 2026 Filed Jun 26, 2026 20:21 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantStock Option (right to buy) · Derivative	22,714	$0.00 Strike: $8.05	$0.00	Disclosure SEC source: 0001628280-26-045783 · wk-form4_1782505294.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,714 Underlying: Common Stock · 22,714 shares Expires 2036-06-23 F2 · derivative.exercise_date: This option award was granted on June 24, 2026. The shares underlying the award shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date. Read SEC document
June 24, 2026 Filed Jun 26, 2026 20:21 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantCommon Stock	15,527	$0.00	$0.00	Disclosure SEC source: 0001628280-26-045783 · wk-form4_1782505294.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,572 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 24, 2026 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date. Read SEC document
January 19, 2026 Filed Jan 21, 2026 21:15 UTC	Quanterix Corp QTRX · Entity 6649	GrantTime-Based Restricted Stock Units · Derivative	1,070,000	$0.00	$0.00	Disclosure SEC source: 0001564777-26-000007 · wk-form4_1769030097.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,883,750 Underlying: Common Stock · 1,070,000 shares Expires 2030-01-20 F2 · derivative.exercise_price: Each time-based RSU represents a contingent right to receive one share of the Issuer's common stock. The time-based RSUs vest as to one-fourth of the total number of shares on each of January 19, 2027, January 19, 2028, January 19, 2029 and January 19, 2030, except as provided for under Section 8(d) or 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026. F2 · derivative.exercise_date: Each time-based RSU represents a contingent right to receive one share of the Issuer's common stock. The time-based RSUs vest as to one-fourth of the total number of shares on each of January 19, 2027, January 19, 2028, January 19, 2029 and January 19, 2030, except as provided for under Section 8(d) or 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026. Read SEC document
January 19, 2026 Filed Jan 21, 2026 21:15 UTC	Quanterix Corp QTRX · Entity 6649	GrantPerformance-Based Restricted Stock Units · Derivative	813,750	$0.00	$0.00	Disclosure SEC source: 0001564777-26-000007 · wk-form4_1769030097.xml · derivative · entry 1 Cunningham Everett · CIK 0001564777 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813,750 Underlying: Common Stock · 813,750 shares Expires 2030-01-20 F1 · derivative.exercise_price: Each performance-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The performance-based RSUs vest upon the volume-weighted average price of the Issuer's common stock meeting certain thresholds within a four-year period, except as provided for under Section 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026. F1 · derivative.exercise_date: Each performance-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The performance-based RSUs vest upon the volume-weighted average price of the Issuer's common stock meeting certain thresholds within a four-year period, except as provided for under Section 8(y) of the Employment Agreement by and between the Issuer and the Reporting Person dated January 8, 2026. Read SEC document
July 05, 2025 Filed Jul 8, 2025 21:59 UTC	ILLUMINA, INC. ILMN · Entity 3137	Tax withholdingCommon Stock	4,248	$97.15	$412,693.20	Disclosure SEC source: 0001127602-25-019032 · form4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,942 Read SEC document
June 25, 2025 Filed Jun 28, 2025 01:08 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantStock Option (right to buy) · Derivative	23,105	$0.00 Strike: $7.80	$0.00	Disclosure SEC source: 0001655759-25-000114 · wk-form4_1751072923.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,105 Underlying: Common Stock · 23,105 shares Expires 2035-06-24 F2 · derivative.exercise_date: This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. Read SEC document
June 25, 2025 Filed Jun 28, 2025 01:08 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantCommon Stock	16,025	$0.00	$0.00	Disclosure SEC source: 0001655759-25-000114 · wk-form4_1751072923.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,045 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	GrantPerformance Shares · Derivative	10,620	$0.00	$0.00	Disclosure SEC source: 0001127602-25-008712 · form4.xml · derivative · entry 7 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,620 Underlying: Common Stock · 10,620 shares Expires 2028-01-02 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	GrantPerformance Shares · Derivative	10,620	$0.00	$0.00	Disclosure SEC source: 0001127602-25-008712 · form4.xml · derivative · entry 6 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,620 Underlying: Common Stock · 10,620 shares Expires 2028-01-02 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2025-2027 with vesting on January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2025-2027, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2025-2027 with vesting on January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2025-2027, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:21 UTC	ILLUMINA, INC. ILMN · Entity 3137	GrantCommon Stock	9,103	$0.00	$0.00	Disclosure SEC source: 0001127602-25-008712 · form4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,190 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2026, February 15, 2027, February 15, 2028, and February 15, 2029, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 227 shares acquired through Employee Stock Purchase Plan. Read SEC document
July 05, 2024 Filed Jul 9, 2024 23:28 UTC	ILLUMINA, INC. ILMN · Entity 3137	GrantPerformance Shares · Derivative	18,430	$0.00	$0.00	Disclosure SEC source: 0001127602-24-020256 · form4.xml · derivative · entry 7 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,430 Underlying: Common Stock · 18,430 shares Expires 2027-01-03 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 3, 2027. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 3, 2027, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 3, 2027. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 3, 2027, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document
July 05, 2024 Filed Jul 9, 2024 23:28 UTC	ILLUMINA, INC. ILMN · Entity 3137	GrantPerformance Shares · Derivative	18,430	$0.00	$0.00	Disclosure SEC source: 0001127602-24-020256 · form4.xml · derivative · entry 6 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,430 Underlying: Common Stock · 18,430 shares Expires 2027-01-03 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2024-2026 with vesting on January 3, 2027 . The number of shares issued will range from 0% to 200% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2024-2026 , relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2024-2026 with vesting on January 3, 2027 . The number of shares issued will range from 0% to 200% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2024-2026 , relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document
July 05, 2024 Filed Jul 9, 2024 23:28 UTC	ILLUMINA, INC. ILMN · Entity 3137	GrantCommon Stock	36,860	$0.00	$0.00	Disclosure SEC source: 0001127602-24-020256 · form4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,860 F1 · shares: Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates. Read SEC document
May 29, 2024 Filed May 31, 2024 21:53 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantStock Option (right to buy) · Derivative	9,070	$0.00 Strike: $33.90	$0.00	Disclosure SEC source: 0001655759-24-000087 · wk-form4_1717192424.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,070 Underlying: Common Stock · 9,070 shares Expires 2034-05-28 F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document
May 29, 2024 Filed May 31, 2024 21:53 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantCommon Stock	5,899	$0.00	$0.00	Disclosure SEC source: 0001655759-24-000087 · wk-form4_1717192424.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,020 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document
May 01, 2024 Filed May 2, 2024 19:00 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	136	$60.15	$8,180.40	Disclosure SEC source: 0000950170-24-052392 · ownership.xml · nonDerivative · entry 3 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,042 F4 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. Read SEC document
April 30, 2024 Filed May 2, 2024 19:00 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantCommon Stock	708	$30.02	$21,254.16	Disclosure SEC source: 0000950170-24-052392 · ownership.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,178 F3 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
April 30, 2024 Filed May 2, 2024 19:00 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantCommon Stock	291	$0.00	$0.00	Disclosure SEC source: 0000950170-24-052392 · ownership.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,470 F1 · shares: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 47,613 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
March 01, 2024 Filed Mar 4, 2024 20:38 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	2,412	$59.32	$143,079.84	Disclosure SEC source: 0001209191-24-004237 · doc4.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,179 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 46,750 shares, Mr. Cunningham also holds, in the aggregate, an additional 90,406 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 29, 2024 Filed Mar 4, 2024 20:38 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	5,291	$0.00	$0.00	Disclosure SEC source: 0001209191-24-004237 · doc4.xml · derivative · entry 4 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,876 Underlying: Common Stock · 5,291 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 29, 2024. The restricted stock units vest in four equal annual installments from the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 29, 2024. The restricted stock units vest in four equal annual installments from the grant date. Read SEC document
February 29, 2024 Filed Mar 4, 2024 20:38 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	5,291	$0.00	$0.00	Disclosure SEC source: 0001209191-24-004237 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
February 27, 2024 Filed Feb 28, 2024 19:37 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	3,648	$56.89	$207,534.72	Disclosure SEC source: 0001209191-24-004080 · doc4.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,300 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 43,871 shares, Mr. Cunningham also holds, in the aggregate, an additional 95,697 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 26, 2024 Filed Feb 28, 2024 19:37 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantRestricted Stock Units · Derivative	31,668	$0.00	$0.00	Disclosure SEC source: 0001209191-24-004080 · doc4.xml · derivative · entry 5 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,668 Underlying: Common Stock · 31,668 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on February 28, 2025. F6 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on February 28, 2025. Read SEC document
February 26, 2024 Filed Feb 28, 2024 19:37 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	7,678	$0.00	$0.00	Disclosure SEC source: 0001209191-24-004080 · doc4.xml · derivative · entry 4 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,356 Underlying: Common Stock · 7,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 26, 2024. The restricted stock units vest in four equal annual installments from the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 26, 2024. The restricted stock units vest in four equal annual installments from the grant date. Read SEC document
February 26, 2024 Filed Feb 28, 2024 19:37 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	7,678	$0.00	$0.00	Disclosure SEC source: 0001209191-24-004080 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
February 22, 2024 Filed Feb 23, 2024 20:00 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	1,350	$59.78	$80,703.00	Disclosure SEC source: 0001209191-24-003920 · doc4.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,270 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 39,841 shares, Mr. Cunningham also holds, in the aggregate, an additional 71,706 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 21, 2024 Filed Feb 23, 2024 20:00 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantCommon Stock	2,711	$0.00	$0.00	Disclosure SEC source: 0001209191-24-003920 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,620 F1 · shares: Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024. Read SEC document
October 12, 2023 Filed Oct 13, 2023 19:59 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	13,007	$66.49	$864,835.43	Disclosure SEC source: 0001209191-23-052803 · doc4.xml · nonDerivative · entry 4 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,909 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan, entered into September 21, 2021, to pay withholding taxes due in connection with the vesting of certain restricted stock units on October 11, 2023. F4 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 38,178 shares, Mr. Cunningham also holds, in the aggregate, an additional 71,707 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
October 11, 2023 Filed Oct 13, 2023 19:59 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	7,501	$0.00	$0.00	Disclosure SEC source: 0001209191-23-052803 · doc4.xml · derivative · entry 7 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,501 Underlying: Common Stock · 7,501 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F7 · derivative.exercise_date: Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024. F7 · derivative.expiration_date: Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024. Read SEC document
October 11, 2023 Filed Oct 13, 2023 19:59 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	20,003	$0.00	$0.00	Disclosure SEC source: 0001209191-23-052803 · doc4.xml · derivative · entry 6 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,004 Underlying: Common Stock · 20,003 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on October 11, 2023. The restricted stock units vest in three equal annual installments beginning on October 11, 2022. F6 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on October 11, 2023. The restricted stock units vest in three equal annual installments beginning on October 11, 2022. Read SEC document
October 11, 2023 Filed Oct 13, 2023 19:59 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	7,501	$0.00	$0.00	Disclosure SEC source: 0001209191-23-052803 · doc4.xml · nonDerivative · entry 3 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
October 11, 2023 Filed Oct 13, 2023 19:59 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	20,003	$0.00	$0.00	Disclosure SEC source: 0001209191-23-052803 · doc4.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
June 15, 2023 Filed Jun 20, 2023 21:26 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantStock Option (right to buy) · Derivative	12,787	$0.00 Strike: $30.33	$0.00	Disclosure SEC source: 0001655759-23-000062 · wk-form4_1687296379.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,787 Underlying: Common Stock · 12,787 shares Expires 2033-06-14 F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document
June 15, 2023 Filed Jun 20, 2023 21:26 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantCommon Stock	4,121	$0.00	$0.00	Disclosure SEC source: 0001655759-23-000062 · wk-form4_1687296379.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,121 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders Read SEC document
May 01, 2023 Filed Oct 13, 2023 19:59 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantCommon Stock	709	$30.02	$21,284.18	Disclosure SEC source: 0001209191-23-052803 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,412 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document
March 01, 2023 Filed Mar 2, 2023 16:07 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	3,628	$62.01	$224,972.28	Disclosure SEC source: 0001209191-23-014598 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,703 F1 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2023. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 22,703 shares, Mr. Cunningham also holds, in the aggregate, an additional 99,211 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 27, 2023 Filed Mar 1, 2023 17:25 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Units · Derivative	7,677	$0.00	$0.00	Disclosure SEC source: 0001209191-23-014260 · doc4.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,034 Underlying: Common Stock · 7,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023. F4 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023. Read SEC document
February 27, 2023 Filed Mar 1, 2023 17:25 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	7,677	$0.00	$0.00	Disclosure SEC source: 0001209191-23-014260 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 26,331 shares, Mr. Cunningham also holds, in the aggregate, an additional 99,211 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
February 24, 2023 Filed Feb 28, 2023 17:25 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantRestricted Stock Units · Derivative	21,167	$0.00	$0.00	Disclosure SEC source: 0001209191-23-013791 · doc4.xml · derivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,167 Underlying: Common Stock · 21,167 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on February 29, 2024. F3 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on February 29, 2024. Read SEC document
December 15, 2022 Filed Dec 19, 2022 22:35 UTC	ARVINAS, INC. ARVN · Entity 5355	GrantCommon Stock · Derivative	30,095	$0.00 Strike: $37.15	$0.00	Disclosure SEC source: 0001655759-22-000077 · wf-form4_167148884711783.xml · derivative · entry 1 Cunningham Everett · CIK 0001564777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,095 Underlying: Common Stock · 30,095 shares Expires 2032-12-14 F1 · derivative.exercise_date: This option award was granted on December 15, 2022. The shares underlying the award shall vest in equal monthly installments through December 14, 2025. Read SEC document
October 12, 2022 Filed Oct 13, 2022 20:57 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	SaleCommon Stock	16,872	$31.37	$529,274.64	Disclosure SEC source: 0001209191-22-053640 · doc4.xml · nonDerivative · entry 4 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,654 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on October 11, 2022. F4 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 18,654 shares, Mr. Cunningham also holds, in the aggregate, an additional 85,720 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
October 11, 2022 Filed Oct 13, 2022 20:57 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Unit · Derivative	15,003	$0.00	$0.00	Disclosure SEC source: 0001209191-22-053640 · doc4.xml · derivative · entry 6 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,002 Underlying: Common Stock · 15,003 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F7 · derivative.exercise_date: Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024. F7 · derivative.expiration_date: Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024. Read SEC document
October 11, 2022 Filed Oct 13, 2022 20:57 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionRestricted Stock Unit · Derivative	20,003	$0.00	$0.00	Disclosure SEC source: 0001209191-22-053640 · doc4.xml · derivative · entry 5 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,007 Underlying: Common Stock · 20,003 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on October 11, 2022. The restricted stock units vest in three equal annual installments beginning on October 11, 2022. F6 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on October 11, 2022. The restricted stock units vest in three equal annual installments beginning on October 11, 2022. Read SEC document
October 11, 2022 Filed Oct 13, 2022 20:57 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	15,003	$0.00	$0.00	Disclosure SEC source: 0001209191-22-053640 · doc4.xml · nonDerivative · entry 3 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
October 11, 2022 Filed Oct 13, 2022 20:57 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	Exercise / conversionCommon Stock	20,003	$0.00	$0.00	Disclosure SEC source: 0001209191-22-053640 · doc4.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document
May 02, 2022 Filed Oct 13, 2022 20:57 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantCommon Stock	520	$47.41	$24,653.20	Disclosure SEC source: 0001209191-22-053640 · doc4.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document
February 25, 2022 Filed Mar 1, 2022 18:25 UTC	EXACT SCIENCES CORP EXAS · Entity 56619	GrantRestricted Stock Units · Derivative	30,711	$0.00	$0.00	Disclosure SEC source: 0001209191-22-014327 · doc4.xml · derivative · entry 1 Cunningham Everett · CIK 0001564777 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,711 Underlying: Common Stock · 30,711 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F3 · balance_after: In addition to the shares of Restricted Stock Units reported on this Form 4, Mr. Cunningham holds, in the aggregate, 120,726 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document
March 04, 2019 Filed Mar 5, 2019 21:26 UTC	QUEST DIAGNOSTICS INC DGX · Entity 2118	SaleCommon Stock	3,892	$86.81	$337,864.52	Disclosure SEC source: 0001022079-19-000088 · wf-form4_155182119111227.xml · nonDerivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,311 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:26 UTC	QUEST DIAGNOSTICS INC DGX · Entity 2118	Tax withholdingCommon Stock	3,777	$86.86	$328,070.22	Disclosure SEC source: 0001022079-19-000088 · wf-form4_155182119111227.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,151 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:26 UTC	QUEST DIAGNOSTICS INC DGX · Entity 2118	GrantCommon Stock	7,669	$86.86	$666,129.34	Disclosure SEC source: 0001022079-19-000088 · wf-form4_155182119111227.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,928 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.